Navigation Links
New Analysis Evaluated Impact of Genetic Variation on Response to Prasugrel
Date:5/5/2009

TOKYO and INDIANAPOLIS, Ind., May 5 /PRNewswire-FirstCall/ -- A new substudy from 1,466 patients from the Phase III TRITON-TIMI 38 clinical trial showed that patients who took prasugrel and had a reduced function of the CYP2C19 gene did not have an increased risk of cardiovascular death, heart attack or stroke compared with those patients who had normal function. The substudy results were published online in Circulation on May 4, 2009(1).

Prasugrel is a "prodrug" that requires the use of cytochrome P450 (CYP) enzymes to convert the drug into the active metabolite. Approximately 30 percent of Caucasians and 60 percent of Asians have reduced function in the CYP2C19 gene, which is part of the CYP system and encodes the enzymes that are responsible for converting prasugrel into its active form(2).

In the substudy, researchers examined how variation in cytochrome P450 (CYP) genes affected the response to prasugrel. In prasugrel-treated patients with acute coronary syndromes (ACS) who underwent an artery-opening procedure known as percutaneous coronary intervention (PCI), the incidence of the combined endpoint of cardiovascular death, heart attack or stroke was 8.5 percent (N=407) in those who carried at least one variant in the CYP2C19 gene that reduced its function versus 9.8 percent (N=1048) in patients without a genetic variant (P=0.27). In addition, the rate of stent thrombosis in carriers of the reduced-function variant in the CYP2C19 gene compared with non-carriers treated with prasugrel was 0.5 percent vs. 1.0 percent, respectively (P=0.48). The results also showed that rates on non-CABG-related TIMI major or minor bleeding did not significantly differ by genetic variant among those treated with prasugrel.

"It is well documented in the medical literature that particular genetic variants in the CYP2C19 gene are associated with an increased risk of cardiovascular outcomes in patients treated with c
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis
2. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
3. New Data From Large Safety Analysis of MYCAMINE Shows Favorable Clinical Safety Profile
4. Immtech Announces Interim Analysis in Phase III African Sleeping Sickness Trial
5. Analysis Shows Vernakalant Hydrochloride Injection Increases Conversion to Normal Heart Rhythm in Acute Atrial Fibrillation Patients Treated Within 48 Hours of Onset
6. New Analysis of Study Data Shows That Asacol(R) (Mesalamine) Delivers Rapid Symptom Relief for Ulcerative Colitis Patients
7. A Sociolinguistic Analysis of In-Office Dialogue Reveals Psychiatrists and Parents Have Significantly Different Perceptions on ADHD and Psychiatric Comorbidities
8. Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results
9. Results Of VYVANSE(TM) (lisdexamfetamine dimesylate) Effect Size Analysis Presented at Major Scientific Meeting
10. Progen Presents Additional Analysis of Data from PI-88 Phase 2 Liver Cancer Study at American Association for the Study of Liver Diseases
11. Retrospective Analysis Finds That Initiation of Insulin Glargine in Patients With Type 2 Diabetes was Associated With a Lower Incidence Rate of Myocardial Infarction as Compared With NPH Insulin

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... Pharmasset, Inc. (Nasdaq... committed to discovering, developing and commerci...orted financial results for the fiscal year ended ...et held $58.4 million in cash, cash equivalents an...and 2009 Highlights ,, RG7128 ,, Phase ...
(Date:11/25/2009)...ov. 25 For many of the m...the 27 million living with untreated hearing loss...diologist Cindy Beyer. ,, Dr. Beyer, senior vic...ca,s largest hearing care and hearing aids compa...ess, frustration, and social isolation, "which can...
(Date:11/25/2009)...RNewswire/ -- Reportlinker.com announces that a ne...ogue: ,, United States Dental Devices Market A...eportlinker.com/p0158733/United-States-Dental-Devi..., United States Dental Devices Market Analysis a...port is an essential source for in-depth informati...
Breaking Medicine Technology:Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Pharmasset Reports Fiscal Year End 2009 Financial Results 9Pharmasset Reports Fiscal Year End 2009 Financial Results 10For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 2For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 13Program Curbs Teen Substance Abuse Delinquency 56342 1Program Curbs Teen Substance Abuse Delinquency 56342 2Even Mild Infections Hasten Decline With Alzheimers 56340 1Even Mild Infections Hasten Decline With Alzheimers 56340 2Even Mild Infections Hasten Decline With Alzheimers 56340 3Researchers find first evidence of virus in malignant prostate cells 9818 1Researchers find first evidence of virus in malignant prostate cells 9818 2Researchers find first evidence of virus in malignant prostate cells 9818 3
(Date:11/27/2009)... , ROCHESTER, N.Y., Nov. 27 /PRNewswire-USNewsw...alth care provider and fortunately every year, new...vention. But do all vaccines boost immunity for th...ional ,booster shots, needed to keep immunity stro...he Journal of the American Academy of Pediatrics, ...
(Date:11/27/2009)..., KIBBUTZ SHAMIR, Israel, Nov. 27 /PRNewswire-F... SHMR ) ( "Shamir" ), a leading provider of innov...ns market, announced today that its board of direc...gregate amount of US$ 10 million (approximately NI...resentative rate of exchange), or approximately US...
(Date:11/27/2009)...g and cycling plus low-emission vehicles may reduc... , FRIDAY, Nov. 27 (HealthDay News) -- Encouragi...ing cars would offer much greater public health be...s, U.K. researchers have found. , The study com...rnative urban land transport scenarios for London,...
(Date:11/27/2009)... , SEATTLE, Nov. 27 /PRNewswire... received record-high Thanksgiving traffic numbers...re Thanksgiving, providing a clear picture of what...r. The average Thanksgiving meal in 2009 weighed i...ase from last year,s feast. According to the Allre...
(Date:11/27/2009)... Multi-purpose bilingual colori...ned for use by the business community to educate -... subjects from Safety issues to Dinosuars to ABC,S... Saint Louis, MO (PRWEB) November 27, 2009 --...ronics or toys to keep them busy any hour of the d...
Breaking Medicine News(10 mins):Health News:Why Some Vaccines May Require A Booster 2Health News:Why Some Vaccines May Require A Booster 3Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 2Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 3Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 4Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2
...rticularly sensitive to cancer-causing pollutants ...regnant women and their newborn babies // .Past st... more harmful to fetuses than their mothers, despi... samples from 265 mothers and their newborn babies...
... in the United States suffer from erectile dysfunc...r men. With exercise and weight loss // , obese me... their sexual function say researchers. Researc...ile function.The study was conducted from October ...
...at estrogen therapy does not decrease, but may inc...en, say researchers //.Previous studies have repor... use and lower risk of dementia. A placebo-cont...esearchers found 47 participants were diagnosed wi...
...ess stress in your 20s could reduce the risk of de...dults who react to // psychological stress with sp...h blood pressure when they are in their 40s. Sp...e. In a large study more than 4,000 participants c...
...gs may be able to anticipate seizures in children ...om the dogs in this study was // licking, often o...whimpering, and “protective" behavior without aggr...alerting canines include Golden Retriever, Standar...
...d patients consume about 40 milligrams of vitamin ...nts of // vitamin C may protect against rheumatoid...women between the ages of 45 and 74. Participants'...t one month and participants who did not consume l...
Other Medicine News:
...doscopic CycloPhotocoagulation (ECP) is a surgical...t, endoscopy and visualized laser application. The...iewed by the surgeon, from the anterior or posteri...e target tissues are easily and accurately identif...
...doscopic CycloPhotocoagulation (ECP) is a surgical...t, endoscopy and visualized laser application. The...iewed by the surgeon, from the anterior or posteri...e target tissues are easily and accurately identif...
...doscopic CycloPhotocoagulation (ECP) is a surgical...t, endoscopy and visualized laser application. The...iewed by the surgeon, from the anterior or posteri...e target tissues are easily and accurately identif...
...doscopic CycloPhotocoagulation (ECP) is a surgical...t, endoscopy and visualized laser application. The...iewed by the surgeon, from the anterior or posteri...e target tissues are easily and accurately identif...
Medicine Products: